Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating income | -$5.45M | -$20.0M | -$64.0M | -$104M | -$125M | -$101M | -$102M |
| Net income | -$5.16M | -$20.0M | -$54.9M | -$95.6M | -$118M | -$96.9M | -$106M |
| EPS (diluted) | -$1.45 | -$1.67 | -$1.49 | -$2.53 | -$3.09 | -$25.19 | -$24.70 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.71M | -$24.1M | -$43.1M | -$72.5M | -$101M | -$97.2M | -$45.7M |
| Capital expenditures | — | $2.32M | $1.57M | $1.14M | $304K | $33.0K | — |
| Free cash flow | — | -$26.4M | -$44.7M | -$73.6M | -$101M | -$97.2M | — |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.06M | $60.6M | $111M | $96.0M | $90.6M | $48.4M | $69.3M |
| Total assets | $2.19M | $280M | $332M | $258M | $160M | $58.8M | $92.2M |
| Total liabilities | $4.86M | $5.28M | $10.9M | $23.0M | $30.1M | $13.9M | $64.4M |
| Shareholders' equity | -$19.7M | $274M | $321M | $235M | $130M | $44.8M | $27.8M |
| Retained earnings | -$21.1M | -$41.0M | -$95.9M | -$192M | -$309M | -$406M | -$512M |
| Shares (wtd avg diluted) | 3.64M | 32.5M | 36.9M | 37.7M | 38.0M | 3.85M | 4.28M |
Every figure is extracted from LeonaBio, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.